Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.

Doppler K, Lindner A, Schütz W, Schütz M, Bornemann A.

Brain Pathol. 2012 Jan;22(1):32-40. doi: 10.1111/j.1750-3639.2011.00510.x. Epub 2011 Aug 16.

PMID:
21672074
2.

Basement membrane remodelling and segmental fibrosis in sporadic inclusion body myositis.

Doppler K, Mittelbronn M, Lindner A, Bornemann A.

Neuromuscul Disord. 2009 Jun;19(6):406-11. doi: 10.1016/j.nmd.2009.04.011. Epub 2009 May 26.

PMID:
19473842
3.

Invasive fibroblasts: fundamental difference between sporadic inclusion body myositis and polymyositis.

Doppler K, Pantazis G, Mack A, Bornemann A.

Muscle Nerve. 2014 Feb;49(2):175-80.

PMID:
23649793
4.

Proteomic analysis of inclusion body myositis.

Li J, Yin C, Okamoto H, Jaffe H, Oldfield EH, Zhuang Z, Vortmeyer AO, Rushing EJ.

J Neuropathol Exp Neurol. 2006 Aug;65(8):826-33.

PMID:
16896316
6.

The nonnecrotic invaded muscle fibers of polymyositis and sporadic inclusion body myositis: on the interplay of chemokines and stress proteins.

De Paepe B, De Bleecker JL.

Neurosci Lett. 2013 Feb 22;535:18-23. doi: 10.1016/j.neulet.2012.11.064. Epub 2013 Jan 4.

PMID:
23295907
7.
8.

Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction.

Paepe BD, Creus KK, Weis J, Bleecker JL.

Neuromuscul Disord. 2012 Jan;22(1):26-33. doi: 10.1016/j.nmd.2011.07.007. Epub 2011 Aug 19.

PMID:
21855341
9.

Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.

Lünemann JD, Schmidt J, Schmid D, Barthel K, Wrede A, Dalakas MC, Münz C.

Ann Neurol. 2007 May;61(5):476-83.

PMID:
17469125
10.

Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.

Schmidt J, Barthel K, Wrede A, Salajegheh M, Bähr M, Dalakas MC.

Brain. 2008 May;131(Pt 5):1228-40. doi: 10.1093/brain/awn053. Epub 2008 Apr 17.

11.

Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.

Güttsches AK, Brady S, Krause K, Maerkens A, Uszkoreit J, Eisenacher M, Schreiner A, Galozzi S, Mertens-Rill J, Tegenthoff M, Holton JL, Harms MB, Lloyd TE, Vorgerd M, Weihl CC, Marcus K, Kley RA.

Ann Neurol. 2017 Feb;81(2):227-239. doi: 10.1002/ana.24847. Epub 2017 Jan 27.

PMID:
28009083
12.

Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.

Schmidt J, Rakocevic G, Raju R, Dalakas MC.

Brain. 2004 May;127(Pt 5):1182-90. Epub 2004 Mar 26.

PMID:
15047591
13.

Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.

Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK.

Neuropathol Appl Neurobiol. 1997 Apr;23(2):132-40.

PMID:
9160898
14.

Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies.

Reimann J, Schnell S, Schwartz S, Kappes-Horn K, Dodel R, Bacher M.

J Neuropathol Exp Neurol. 2010 Jun;69(6):654-62. doi: 10.1097/NEN.0b013e3181e10925.

PMID:
20467327
15.

Inclusion body myositis: laser microdissection reveals differential up-regulation of IFN-γ signaling cascade in attacked versus nonattacked myofibers.

Ivanidze J, Hoffmann R, Lochmüller H, Engel AG, Hohlfeld R, Dornmair K.

Am J Pathol. 2011 Sep;179(3):1347-59. doi: 10.1016/j.ajpath.2011.05.055.

16.

Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy.

Zanusso G, Vattemi G, Ferrari S, Tabaton M, Pecini E, Cavallaro T, Tomelleri G, Filosto M, Tonin P, Nardelli E, Rizzuto N, Monaco S.

Brain Pathol. 2001 Apr;11(2):182-9.

PMID:
11303793
17.

Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota.

Wilson FC, Ytterberg SR, St Sauver JL, Reed AM.

J Rheumatol. 2008 Mar;35(3):445-7. Epub 2008 Jan 15.

PMID:
18203321
18.

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

Pluk H, van Hoeve BJ, van Dooren SH, Stammen-Vogelzangs J, van der Heijden A, Schelhaas HJ, Verbeek MM, Badrising UA, Arnardottir S, Gheorghe K, Lundberg IE, Boelens WC, van Engelen BG, Pruijn GJ.

Ann Neurol. 2013 Mar;73(3):397-407. doi: 10.1002/ana.23822. Epub 2013 Mar 4.

PMID:
23460448
19.

Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.

Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Vianna MA, Sachetti S, Marie SK.

Autoimmun Rev. 2006 Feb;5(2):93-100. Epub 2005 Jun 17. Review.

PMID:
16431335
20.

T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.

Hiniker A, Daniels BH, Margeta M.

J Neuropathol Exp Neurol. 2016 Mar;75(3):239-45. doi: 10.1093/jnen/nlv023. Epub 2016 Feb 3.

Supplemental Content

Support Center